Top

11-11-2014 | Spondyloarthropathies | Review | Article

The changing clinical picture and epidemiology of spondyloarthritis

Journal: Nature Reviews Rheumatology

Publisher: Nature Publishing Group UK

Abstract

In the past decade, major progress has been made in the recognition, classification and treatment of spondyloarthritis (SpA). Classification criteria have been developed for axial and peripheral SpA by the Assessment of SpondyloArthritis international Society (ASAS) as a response to new insight into the clinical picture and unmet needs. The ASAS criteria have contributed to a better understanding of the full spectrum of axial and peripheral SpA and of the potential for treatment. However, whether all patients fulfilling these criteria should be considered as having true SpA is a matter of debate. Furthermore, the implementation of the ASAS criteria might lead to an increase in the reported prevalence of SpA, as patients who were previously unidentified could now be classified as having the disease, which might have consequences for healthcare budgets. In this Review, the changes in the clinical picture and epidemiology of SpA are discussed in light of the ASAS classification criteria for SpA.

Nat Rev Rheumatol 2015;11:110–118. doi:10.1038/nrrheum.2014.181

Khan, M. A. Update on spondyloarthropathies. Ann. Intern. Med. 136, 896–907 (2002).CrossRef

Rudwaleit, M. New approaches to diagnosis and classification of axial and peripheral spondyloarthritis. Curr. Opin. Rheumatol. 22, 375–380 (2010).CrossRef

Rudwaleit, M. et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann. Rheum. Dis. 68, 777–783 (2009).CrossRef

Rudwaleit, M. et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 70, 25–31 (2011).CrossRef

Rudwaleit, M., van der Heijde, D., Khan, M. A., Braun, J. & Sieper, J. How to diagnose axial spondyloarthritis early. Ann. Rheum. Dis. 63, 535–543 (2004).CrossRef

van der Linden, S., Valkenburg, H. A. & Cats, A. Evaluation of diagnostic criteria for AS. A proposal for modification of the New York criteria. Arthritis Rheum. 27, 361–368 (1984).CrossRef

Amor, B., Dougados, M. & Mijiyawa, M. Criteria of the classification of spondylarthropathies [French]. Rev. Rhum. Mal. Osteoartic. 57, 85–89 (1990).PubMed

Dougados, M. et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 34, 1218–1227 (1991).CrossRef

Braun, J. et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum. 37, 1039–1045 (1994).CrossRef

10.

Oostveen, J., Prevo, R., den Boer, J. & van de Laar, M. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J. Rheumatol. 26, 1953–1958 (1999).PubMed

11.

Pedersen, S. J., Weber, U. & Ostergaard, M. The diagnostic utility of MRI in spondyloarthritis. Best Pract. Res. Clin. Rheumatol. 26, 751–766 (2012).CrossRef

12.

Baeten, D., Breban, M., Lories, R., Schett, G. & Sieper, J. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum. 65, 12–20 (2013).CrossRef

13.

Weber, U. et al. The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum. 62, 3048–3058 (2010).CrossRef

14.

Aydin, S. Z. et al. Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann. Rheum. Dis. 71, 56–60 (2012).CrossRef

15.

Weber, U. et al. Development and validation of a magnetic resonance imaging reference criterion for defining a positive sacroiliac joint magnetic resonance imaging finding in spondyloarthritis. Arthritis Care Res. (Hoboken) 65, 977–985 (2013).CrossRef

16.

van den Berg, R. et al. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort. Ann. Rheum. Dis. 72, 1646–1653 (2013).CrossRef

17.

van den Berg, R. et al. Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 52, 1492–1499 (2013).CrossRef

18.

Moltó, A. et al. Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-204262.

19.

van der Heijde, D. et al. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 66, 667–673 (2014).CrossRef

20.

Rudwaleit, M. et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann. Rheum. Dis. 68, 1520–1527 (2009).CrossRef

21.

Rudwaleit, M. et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 60, 717–727 (2009).CrossRef

22.

Kiltz, U. et al. The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study. Ann. Rheum. Dis. 71, 1207–1211 (2012).CrossRef

23.

Kiltz, U. et al. Do patients with non-radiographic axial spondylarthritis differ from patients with AS? Arthritis Care Res. (Hoboken) 64, 1415–1422 (2012).CrossRef

24.

Ciurea, A. et al. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum. 65, 3096–3106 (2013).CrossRef

25.

Callhoff, J., Sieper, J., Weiss, A., Zink, A. & Listing, J. Efficacy of TNFα blockers in patients with AS and non-radiographic axial spondyloarthritis: a meta-analysis. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2014-205322.

26.

Landewé, R., Dougados, M., Mielants, H., van der Tempel, H. & van der Heijde, D. Physical function in AS is independently determined by both disease activity and radiographic damage of the spine. Ann. Rheum. Dis. 68, 863–867 (2009).CrossRef

27.

Koumakis, E. et al. Heel pain in spondyloarthritis: results of a cross-sectional study of 275 patients. Clin. Exp. Rheumatol. 30, 487–491 (2012).PubMed

28.

de Carvalho, H. M. et al. Gender characterization in a large series of Brazilian patients with spondyloarthritis. Clin. Rheumatol. 31, 687–695 (2012).CrossRef

29.

Dougados, M. et al. A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial. Ann. Rheum. Dis. 69, 1430–1435 (2010).CrossRef

30.

Paramarta, J. E. et al. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without AS or psoriatic arthritis. Ann. Rheum. Dis. 72, 1793–1799 (2013).CrossRef

31.

Stolwijk, C., Boonen, A., Van Tubergen, A. & Reveille, J. D. Epidemiology of spondyloarthritis. Rheum. Dis. Clin. North Am. 38, 441–476 (2012).CrossRef

32.

Feldtkeller, E., Khan, M. A., van der Heijde, D., Van der Linden, S. & Braun, J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with AS. Rheumatol. Int. 23, 61–66 (2003).CrossRef

33.

Sampaio-Barros, P. D., Conde, R. A., Bonfiglioli, R., Bértolo, M. B. & Samara, A. M. Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol. Int. 26, 1143–1146 (2006).CrossRef

34.

Marzo-Ortega, H. et al. Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. Ann. Rheum. Dis. 68, 1721–1727 (2009).CrossRef

35.

Chung, H. Y., Machado, P., van der Heijde, D., D'Agostino, M. A. & Dougados, M. HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis. Ann. Rheum. Dis. 70, 1930–1936 (2011).CrossRef

36.

Akkoc, N. Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review. Curr. Rheumatol. Rep. 10, 371–378 (2008).CrossRef

37.

Reveille, J. D., Witter, J. P. & Weisman, M. H. Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res. (Hoboken) 64, 905–910 (2012).CrossRef

38.

Hukuda, S. et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J. Rheumatol. 28, 554–559 (2001).PubMed

39.

Boyer, G. S. et al. Prevalence of spondyloarthropathies in Alaskan Eskimos. J. Rheumatol. 21, 2292–2297 (1994).PubMed

40.

Alexeeva, L. et al. Prevalence of spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia. J. Rheumatol. 21, 2298–2300 (1994).PubMed

41.

Muñoz-Fernández, S. et al. Early spondyloarthritis: results from the pilot registry ESPIDEP. Clin. Exp. Rheumatol. 28, 498–503 (2010).PubMed

42.

Bhatia, K., Prasad, M. L., Barnish, G. & Koki, G. Antigen and haplotype frequencies at three human leucocyte antigen loci (HLA-A, -B, -C) in the Pawaia of Papua New Guinea. Am. J. Phys. Anthropol. 75, 329–340 (1988).CrossRef

43.

Gofton, J. P., Chalmers, A., Price, G. E. & Reeve, C. E. HL-A and AS in, B. C. Indians. J. Rheumatol. 11, 572–573 (1984).PubMed

44.

Benevolenskaia, L. I., Erdes, S., Krylov, M. & Chekalina, N. A. The epidemiology of spondyloarthropathies among the native inhabitants of Chukotka. 2. The prevalence of HLA-B27 in the population and among spondyloarthropathy patients [Russian]. Ter Arkh 66, 41–44 (1994).PubMed

45.

Gran, J. T., Mellby, A. S. & Husby, G. The prevalence of HLA-B27 in Northern Norway. Scand. J. Rheumatol. 13, 173–176 (1984).CrossRef

46.

Gran, J. T., Husby, G. & Hordvik, M. Prevalence of AS in males and females in a young middle-aged population of Tromso, northern Norway. Ann. Rheum. Dis. 44, 359–367 (1985).CrossRef

47.

Johnsen, K., Gran, J. T., Dale, K. & Husby, G. The prevalence of AS among Norwegian Samis (Lapps). J. Rheumatol. 19, 1591–1594 (1992).PubMed

48.

Khan, M. A. HLA-B27 and its subtypes in world populations. Curr. Opin. Rheumatol. 7, 263–269 (1995).CrossRef

49.

Mustafa, K. N., Hammoudeh, M. & Khan, M. A. HLA-B27 Prevalence in Arab populations and among patients with AS. J. Rheumatol. 39, 1675–1677 (2012).CrossRef

50.

Costantino, F. et al. Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-204436.

51.

Geirsson, A. J., Eyjolfsdottir, H., Bjornsdottir, G., Kristjansson, K. & Gudbjornsson, B. Prevalence and clinical characteristics of AS in Iceland—a nationwide study. Clin. Exp. Rheumatol. 28, 333–340 (2010).PubMed

52.

Carbone, L. D. et al. Ankylosing spondylitis in Rochester, Minnesota, 1935–1989 Is the epidemiology changing? Arthritis Rheum. 35, 1476–1482 (1992).CrossRef

53.

Bakland, G., Nossent, H. C. & Gran, J. T. Incidence and prevalence of AS in Northern Norway. Arthritis Rheum. 53, 850–855 (2005).CrossRef

54.

Dean, L. E. et al. Global prevalence of AS. Rheumatology (Oxford) 53, 650–657 (2014).CrossRef

55.

Bakland, G., Alsing, R., Singh, K. & Nossent, J. C. Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27. Arthritis Care Res. (Hoboken) 65, 448–453 (2013).CrossRef

56.

Strand, V. et al. Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res. (Hoboken) 65, 1299–1306 (2013).CrossRef

57.

Van Tubergen, A. & Weber, U. Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat. Rev. Rheumatol. 8, 253–261 (2012).CrossRef

58.

Savolainen, E., Kaipiainen-Seppanen, O., Kröger, L. & Luosujärvi, R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J. Rheumatol. 30, 2460–2468 (2003).PubMed

59.

De Angelis, R., Salaffi, F. & Grassi, W. Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand. J. Rheumatol. 36, 14–21 (2007).CrossRef

60.

Townes, J. M. et al. Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Ann. Rheum. Dis. 67, 1689–1696 (2008).CrossRef

61.

Söderlin, M. K., Borjesson, O., Kautiainen, H., Skogh, T. & Leirisalo-Repo, M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann. Rheum. Dis. 61, 911–915 (2002).CrossRef

62.

Saraux, A. et al. Prevalence of spondyloarthropathies in France: 2001. Ann. Rheum. Dis. 64, 1431–1435 (2005).CrossRef

63.

Van Hoeven, L., Luime, J., Han, H., Vergouwe, Y. & Weel, A. Identifying axial spondyloarthritis in Dutch primary care patients, ages 20–45 years, with chronic low back pain. Arthritis Care Res. (Hoboken) 66, 446–453 (2014).CrossRef

64.

Sieper, J. & van der Heijde, D. Review: Nonradiographic axial spondyloarthritis: new definition of an old disease? Arthritis Rheum. 65, 543–551 (2013).CrossRef

65.

Poddubnyy, D. et al. The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic. Ann. Rheum. Dis. 71, 1998–2001 (2012).CrossRef

66.

Bennett, A. N. et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident AS at eight years. Arthritis Rheum. 58, 3413–3418 (2008).CrossRef

67.

Poddubnyy, D. et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann. Rheum. Dis. 70, 1369–1374 (2011).CrossRef

68.

Gong, Y. et al. Ten years' experience with needle biopsy in the early diagnosis of sacroiliitis. Arthritis Rheum. 64, 1399–1406 (2012).CrossRef

69.

Braun, J. et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 41, 58–67 (1998).CrossRef

70.

Haglund, E. et al. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann. Rheum. Dis. 70, 943–948 (2011).CrossRef

71.

Saraux, A. et al. Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Societe de Rhumatologie de l'Ouest. J. Rheumatol. 26, 2622–2627 (1999).PubMed

72.

Smolen, J. S. et al. Treating spondyloarthritis, including AS and psoriatic arthritis, to target: recommendations of an international task force. Ann. Rheum. Dis. 73, 6–16 (2014).CrossRef

73.

Van der Burg, L. R., Ter Wee, M. M. & Boonen, A. Effect of biological therapy on work participation in patients with AS: a systematic review. Ann. Rheum. Dis. 71, 1924–1933 (2012).CrossRef

Medicine Matters Rheumatology

Abstract